Medicare Enrolled
Dr. Vlassi Baktidy, MD
Pulmonary Disease · Plainview, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baktidy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baktidy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baktidy
Dr. Vlassi Baktidy is a pulmonary disease specialist in Plainview, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Baktidy performed 3,059 Medicare services across 2,225 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baktidy received a total of $6,770 from 35 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baktidy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 12% volume in NY
$6,770 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,059
Medicare services
Top 12% in NY for pulmonary disease
2,225
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
914 | $77 | $291 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
867 | $109 | $411 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
135 | $146 | $587 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
113 | $8 | $33 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
103 | $10 | $44 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
92 | $13 | $62 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
77 | $6 | $28 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
66 | $8 | $34 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
64 | $52 | $290 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
63 | $50 | $246 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
60 | $36 | $312 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
55 | $16 | $78 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
54 | $2 | $10 |
| Hemoglobin measurement A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
53 | $5 | $20 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
49 | $14 | $85 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
45 | $10 | $47 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
45 | $7 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
40 | $13 | $156 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $152 | $584 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
28 | $80 | $1,334 |
| PSA test (prostate cancer screening) | 24 | $18 | $85 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $106 | $398 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
21 | $149 | $615 |
| New patient office visit, complex (60-74 min) | 15 | $193 | $743 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
12 | $17 | $85 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
12 | $581 | $2,858 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,770
Total received (2018-2024)
Avg $967/year across 7 years
Top 25% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,488 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$282 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,733
2023
$1,316
2022
$1,213
2021
$1,110
2020
$598
2019
$534
2018
$266
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$324
GlaxoSmithKline, LLC.
$290
Actelion Pharmaceuticals US, Inc.
$169
Regeneron Healthcare Solutions, Inc.
$155
HARMONY BIOSCIENCES LLC
$123
GENZYME CORPORATION
$96
Mylan Specialty L.P.
$94
Philips North America LLC
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
Baxter Healthcare
$77
JAZZ PHARMACEUTICALS INC.
$64
Amgen Inc.
$56
ZOLL Respicardia, Inc.
$34
Resmed Corp
$24
Grifols USA, LLC
$23
Electromed, Inc.
$21
Axsome Therapeutics, Inc.
$13
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,702
AstraZeneca Pharmaceuticals LP
$1,061
Boehringer Ingelheim Pharmaceuticals, Inc.
$865
Regeneron Healthcare Solutions, Inc.
$431
Mylan Specialty L.P.
$310
JAZZ PHARMACEUTICALS INC.
$292
GENZYME CORPORATION
$259
Actelion Pharmaceuticals US, Inc.
$169
Philips Electronics North America Corporation
$149
Baxter Healthcare
$148
HARMONY BIOSCIENCES LLC
$139
Electromed, Inc.
$129
United Therapeutics Corporation
$123
Advanced Respiratory, Inc
$113
Philips North America LLC
$90
Genentech USA, Inc.
$87
Amgen Inc.
$71
Harmony Biosciences LLC
$70
Merck Sharp & Dohme LLC
$61
Resmed Corp
$54
Takeda Pharmaceuticals U.S.A., Inc.
$54
Grifols USA, LLC
$51
Novartis Pharmaceuticals Corporation
$47
PFIZER INC.
$46
Insmed, Inc.
$40
ZOLL Respicardia, Inc.
$34
Merck Sharp & Dohme Corporation
$28
Teva Pharmaceuticals USA, Inc.
$28
Sunovion Pharmaceuticals Inc.
$27
Mallinckrodt Hospital Products Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$15
Ventec Life Systems, Inc.
$15
Shire North American Group Inc
$14
Axsome Therapeutics, Inc.
$13
Jazz Pharmaceuticals Inc.
$12
Top 3 companies account for 53.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · GARDASIL 9 · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · PNEUMOVAX 23 · PREVNAR - 13 · Prolastin-C Liquid · QUVIVIQ · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · WAKIX · Wakix · Wellcentive Undiv · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
339
Per 100K population
24.4
County median income
$143,408
Nearest hospital
PLAINVIEW HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Baktidy is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Baktidy experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Baktidy performed 914 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baktidy receive payments from pharmaceutical companies?
Yes. Dr. Baktidy received a total of $6,770 from 35 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baktidy's costs compare to other pulmonary diseases in Plainview?
Dr. Baktidy's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baktidy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Plainview
Browse pulmonary diseases in Plainview ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology